Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("KURUVILLA, John")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 17 of 17

  • Page / 1
Export

Selection :

  • and

Treatment of newly diagnosed advanced stage Hodgkin lymphomaUHM, Jieun; KURUVILLA, John.Blood reviews. 2012, Vol 26, Num 4, pp 167-174, issn 0268-960X, 8 p.Article

How I treat relapsed and refractory Hodgkin lymphomaKURUVILLA, John; KEATING, Armand; CRUMP, Michael et al.Blood. 2011, Vol 117, Num 16, pp 4208-4217, issn 0006-4971, 10 p.Article

MicroRNA Signature Obtained From the Comparison of Aggressive With Indolent Non-Hodgkin Lymphomas: Potential Prognostic Value in Mantle-Cell LymphomaGOSWAMI, Rashmi S; ATENAFU, Eshetu G; LAI, Raymond et al.Journal of clinical oncology. 2013, Vol 31, Num 23, pp 2903-2911, issn 0732-183X, 9 p.Article

Limited benefit of pentostatin salvage therapy for steroid-refractory grade III-IV acute graft-versus-host diseaseALAM, Naheed; ATENAFU, Eshetu G; TSE, Garwin et al.Clinical transplantation. 2013, Vol 27, Num 6, pp 930-937, issn 0902-0063, 8 p.Article

Autologous and Allogeneic Stem-Cell Transplantation for Transformed Follicular Lymphoma: A Report of the Canadian Blood and Marrow Transplant GroupVILLA, Diego; CRUMP, Michael; RUBINGER, Morel et al.Journal of clinical oncology. 2013, Vol 31, Num 9, pp 1164-1171, issn 0732-183X, 8 p.Article

Different response to salvage chemotherapy but similar post-transplant outcomes in patients with relapsed and refractory Hodgkin's lymphomaPUIG, Noemi; PINTILIE, Melania; SESHADRI, Tara et al.Haematologica (Roma). 2010, Vol 95, Num 9, pp 1496-1502, issn 0390-6078, 7 p.Article

Clinical efficacy of prophylactic strategy of long-term low-dose acyclovir for Varicella-Zoster virus infection after allogeneic peripheral blood stem cell transplantationDONG HWAN KIM; KUMAR, Deepali; MESSNER, Hans A et al.Clinical transplantation. 2008, Vol 22, Num 6, pp 770-779, issn 0902-0063, 10 p.Article

Autologous Stem Cell Transplantation in Follicular Lymphoma: a Systematic Review and Meta-analysisAL KHABORI, Murtadha; DE ALMEIDA, John R; GUYATT, Gordon H et al.Journal of the National Cancer Institute. 2012, Vol 104, Num 1, pp 18-28, issn 0027-8874, 11 p.Article

Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survivalJOHNSON, Nathalie A; SAVAGE, Kerry J; CONNORS, Joseph M et al.Blood. 2009, Vol 114, Num 11, pp 2273-2279, issn 0006-4971, 7 p.Article

Phase IA/II, multicentre, open-label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non-Hodgkin or Hodgkin lymphomaFANALE, Michelle; ASSOULINE, Sarit; DYER, Martin J. S et al.British journal of haematology. 2014, Vol 164, Num 2, pp 258-265, issn 0007-1048, 8 p.Article

Second-line salvage chemotherapy for transplant-eligible patients with Hodgkin's lymphoma resistant to platinum-containing first-line salvage chemotherapyVILLA, Diego; SESHADRI, Tara; PUIG, Noemi et al.Haematologica (Roma). 2012, Vol 97, Num 5, pp 751-757, issn 0390-6078, 7 p.Article

Permanent Right-to-Left Shunt Is the Key Factor in Managing Patent Foramen OvaleRIGATELLI, Gianluca; DELL'AVVOCATA, Fabio; NANJUNDAPPA, Aravinda et al.Journal of the American College of Cardiology. 2011, Vol 58, Num 21, pp 2257-2261, issn 0735-1097, 5 p.Article

Similar response rates and superior early progression-free survival with gemcitabine, dexamethasone, and cisplatin salvage therapy compared with carmustine, etoposide, cytarabine, and melphalan salvage therapy prior to autologous stem cell transplantation for recurrent or refractory Hodgkin lymphomaKURUVILLA, John; NAGY, Tracy; PINTILIE, Melania et al.Cancer. 2006, Vol 106, Num 2, pp 353-360, issn 0008-543X, 8 p.Article

Multiple Single-Nucleotide Polymorphism―Based Risk Model for Clinical Outcomes After Allogeneic Stem-Cell Transplantation, Especially for Acute Graft-Versus-Host DiseaseKIM, Dennis; YUN, Jina; LIPTON, Jeffrey H et al.Transplantation. 2012, Vol 94, Num 12, pp 1250-1257, issn 0041-1337, 8 p.Article

Phase I Dose Finding Studies of Obatoclax (GX15-070), a Small Molecule Pan-BCL-2 Family Antagonist, in Patients with Advanced Solid Tumors or LymphomaHWANG, Jimmy J; KURUVILLA, John; MENDELSON, David et al.Clinical cancer research (Print). 2010, Vol 16, Num 15, pp 4038-4045, issn 1078-0432, 8 p.Article

Prospective assessment of the natural history of positive D-dimer results in persons with acute venous thromboembolism (DVT or PE)KURUVILLA, John; WELLS, Phil S; MORROW, Bev et al.Thrombosis and haemostasis. 2003, Vol 89, Num 2, pp 284-287, issn 0340-6245, 4 p.Article

Aplastic anemia following administration of a tumor necrosis factor-α inhibitorKURUVILLA, John; LEITCH, Heather A; VICKARS, Linda M et al.European journal of haematology. 2003, Vol 71, Num 5, pp 396-398, issn 0902-4441, 3 p.Article

  • Page / 1